Condition: Colon Cancer · Sponsor: University Hospital, Rouen
The aim of this study is to determine whether chemotherapy prior to tumor removal (neoadjuvant chemotherapy), in patients undergoing treatment for colon cancer in occlusion (CCO), would improve the rate of patients able to benefit from "optimal" treatment, i.e. complete treatment (including all neoadjuvant and adjuvant chemotherapy cures). This new strategy, which would combine chemotherapy before surgery and possibly post-operatively (depending on tumor analysis), could improve the prognosis of occluded colon cancers by treating circulating micrometastases and/or inducing a reduction in tumor size, thereby increasing the rate of complete resection.
This description comes directly from the study's public registry record.
Valérie Bridoux · 0232881347 · valerie.bridoux@chu-rouen.fr
Julie Rondeaux, PhD · 0232885427 · julie.rondeaux@chu-rouen.fr
Always discuss trial participation with your own doctor first.
| Chu Amiens | Amiens, France | Recruiting |
| Chr Beauvais | Beauvais, France | Recruiting |
| Chru Besancon | Besançon, France | Recruiting |
| Aphp Avicenne | Bobigny, France | Recruiting |
| CHU CAEN | Caen, France | Recruiting |
| Aphp Antoine Beclere | Clamart, France | Recruiting |
| Chu Colmar | Colmar, France | Recruiting |
| Chu Dijon | Dijon, France | Recruiting |
| Chu Grenoble | Grenoble, France | Recruiting |
| Aphp Kremlin Bicetre | Le Kremlin-Bicêtre, France | Recruiting |
| Chru Lille | Lille, France | Recruiting |
| Chru Lille | Lille, France | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06107920